DOXY 200 Drug Patent Profile
✉ Email this page to a colleague
When do Doxy 200 patents expire, and what generic alternatives are available?
Doxy 200 is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in DOXY 200 is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxy 200
A generic version of DOXY 200 was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOXY 200?
- What are the global sales for DOXY 200?
- What is Average Wholesale Price for DOXY 200?
Summary for DOXY 200
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 438 |
| DailyMed Link: | DOXY 200 at DailyMed |
Pharmacology for DOXY 200
| Drug Class | Tetracycline-class Drug |
US Patents and Regulatory Information for DOXY 200
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | DOXY 200 | doxycycline hyclate | INJECTABLE;INJECTION | 062475-002 | Dec 9, 1983 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
